EU Panel Backs Dolutegravir/Lamivudine Combo Pill for HIV EU Panel Backs Dolutegravir/Lamivudine Combo Pill for HIV

Dovato contains 50 mg dolutegravir and 300 mg lamivudine and would be the first once-daily, single-pill, completed 2-drug regimen for treatment of HIV in Europe.International Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: HIV/AIDS News Alert Source Type: news